Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ares Commercial Real Estate Corporation Common Stock (NY:ACRE)

4.995 +0.035 (+0.71%)
Streaming Delayed Price Updated: 2:24 PM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ares Commercial Real Estate Corporation Common Stock

< Previous 1 2 3 Next >
News headline image
Ares Commercial (ACRE) Q4 2025 Earnings Transcript ↗
Ares Commercial (ACRE) Q4 2025 Earnings Transcript 
Via The Motley Fool
Ares Commercial Real Estate (NYSE:ACRE) Reports Mixed Q4 Results, Beats on Distributable Earnings ↗
Via Chartmill
News headline image
Wall Street's Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 10% Dividend Yields ↗
 
Via Benzinga
News headline image
ARES COMMERCIAL REAL ESTATE (NYSE:ACRE) Reports Strong Q3 2025 Earnings Beat ↗
Ares Commercial Real Estate (ACRE) crushed Q3 2025 earnings estimates, with EPS and revenue far exceeding expectations. The company reported strong profitability and strategic progress. 
Via Chartmill
News headline image
Earnings Outlook For Ares Comml Real Est ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 7, 2025 ↗
 
Via Benzinga
News headline image
Insights into Ares Comml Real Est's Upcoming Earnings ↗
 
Via Benzinga
News headline image
Deep Dive Into Ares Comml Real Est Stock: Analyst Perspectives (4 Ratings) ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 12, 2025 ↗
 
Via Benzinga
News headline image
Analyst Ratings For Ares Comml Real Est ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 7, 2025 ↗
 
Via Benzinga
News headline image
ACRE's Shrinking Margins Signal Troubled Waters: What's Next for Commercial Real Estate and Investors?
Ares Commercial Real Estate Corporation (NYSE: ACRE) is navigating a turbulent financial landscape, with recent reports revealing a significant contraction in its margin trends. The commercial real... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Demystifying Ares Comml Real Est: Insights From 4 Analyst Reviews ↗
 
Via Benzinga
News headline image
ACRE Earnings Miss With 25% Sales Drop ↗
Via The Motley Fool
Topics Earnings
News headline image
Mortgage Applications Dip As Rates Climb: 'It Is Still Cheaper To Rent Than Purchase For 82 Out Of 97 Major Cities' ↗
U.S. mortgage market hit speed bump as rates rise, breaking 5-week growth streak. Buyers remain active, but still face challenges. 
Via Benzinga
News headline image
Ares Commercial Real Estate: Problems Lurk For This 13.7% Yielder ↗
In January 2024, Ares reduced its quarterly dividend to $0.25 per share, from $0.33. It was the first time the company lowered the dividend since it began paying one in 2012. 
Via Talk Markets
Topics Real Estate & REITs
News headline image
3 High Yield Mortgage REITs Yielding Over 8% ↗
Mortgage REITs are very attractive dividend stocks for high yields. 
Via Talk Markets
News headline image
ACRE Stock Earnings: Ares Comml Real Est Misses EPS, Misses Revenue for Q2 2024 ↗
ACRE stock results show that Ares Comml Real Est missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Ares Comml Real Est Earnings Preview ↗
 
Via Benzinga
News headline image
ACRE Stock Earnings: Ares Comml Real Est Misses EPS, Beats Revenue for Q1 2024 ↗
ACRE stock results show that Ares Comml Real Est missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Insiders Buying General American Investors Company And 2 Other Stocks ↗
Although U.S. stocks closed mixed on Wednesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Watch Out - These 5 REITs Could Be Yield Traps ↗
 
Via Benzinga
News headline image
Wall Street's Top 10 Stock Calls This Week - Saturday, March 9 ↗
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of March 4-8. 
Via Talk Markets
News headline image
Dividends By The Numbers In February 2024 ↗
Over the past year, stock market dividends have consistently featured two major themes when their year-over-year changes are measured. 
Via Talk Markets
News headline image
Downgrades Flood In For Commercial Real Estate Stocks: Analysts Warn Of 'Rocky Road Ahead' ↗
Bank of America has downgraded six Commercial Real Estate mortgage REITs. Here's why. 
Via Benzinga
News headline image
Wall Street's Most Accurate Analysts Say Hold These 3 Financial Stocks With Over 12% Dividend Yields ↗
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
News headline image
Top 4 Financial Stocks Which Could Rescue Your Portfolio This Quarter ↗
The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Sticky Inflation, Surging Treasury Yields Push Mortgage Rates To 2-Month Peak: Real Estate Stocks Tumble ↗
U.S. housing market faces pressure as mortgage rates rise to 6.87%, highest in 2 months. Inflation data and bond yields trigger market sell-off. 
Via Benzinga
Topics Bonds Economy
News headline image
Earnings Scheduled For November 3, 2023 ↗
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.